As mentioned above, for ABCA1, lncRNA CDKN2B-AS1 also significantly decreases the ABCG1 level in human foam cells, inhibiting the expression of CDKN2B, which can lead to the suppression of RCT and progression of atherosclerosis [237]. Here, CDKN2B is linked to atherosclerosis.